您的当前位置:首页 > 行业数据 > 常见肿瘤药物相关血小板减少(CTIT)发生率及其3/4级占比举例
图片属性
图片格式:PNG 图片大小:384KB 图片尺寸:1798*987
同报告图片
 / 4
常见肿瘤药物相关血小板减少(CTIT)发生率及其3/4级占比举例_第1页
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
常见肿瘤药物相关血小板减少(CTIT)发生率及其3/4级占比举例_第2页
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
常见肿瘤药物相关血小板减少(CTIT)发生率及其3/4级占比举例_第3页
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
常见肿瘤药物相关血小板减少(CTIT)发生率及其3/4级占比举例_第4页
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOWRmOW3peaMgeiCoeiuoeWIkuiAg+aguOmhueebriAgICAgICAgIHwgMjAyMiAgfCAyMDIzICB8IDIwMjQgIHwgMjAyNSAgfCAyMDI2ICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18Cnwg5Yib5paw6I2v5pS25YWl77yI5Lq/5YWD77yM5ZCr56iO77yJICAgICB8IDg1ICAgIHwgMTA1ICAgfCAxMzAgICB8IDE2NSAgIHwgMjA4ICAgfAp8IOaUtuWFpVlPWSAgICAgICAgICAgICAgICAgICB8IDIzLjUzJXwgMjMuODElfCAyNi45MiV8IDI2LjA2JXwgICAgICAgfAp8IOaWsOWIhuWtkElOROaVsOmHj++8iOS4qu+8iSAgICAgICAgIHwgMTAgICAgfCAxMSAgICB8IDEyICAgIHwgMTMgICAgfCAxNCAgICB8Cnwg5Yib5paw6I2vTkRB6I635Y+X55CG5pWw6YeP77yI5Liq77yM5YyF5ZCr5paw6YCC5bqU55eH77yJIHwgNiAgICAgfCA3ICAgICB8IDYgICAgIHwgNSAgICAgfCA0ICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlhazlkYrvvIzmtZnllYbor4HliLjnoJTnqbbmiYA=
常见肿瘤药物相关血小板减少(CTIT)发生率及其3/4级占比举例_第5页
所属报告: 恒瑞医药-公司深度报告:创新&国际化双驱加速拐点-241224(36页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠